Epinephrine Bitartrate, Lidocaine Hydrochloride Injection — FDA Drug Shortage

Current — Fresenius Kabi USA, LLC

The FDA lists a drug shortage record for Epinephrine Bitartrate, Lidocaine Hydrochloride Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on Oct 14, 2016. Reported reason: Other

Shortage details

Status
Current
Company
Fresenius Kabi USA, LLC
Package NDC
63323-489-27
Dosage Form
Injection
Presentation
Xylocaine, Injection, .005 mg/1 mL; 20 mg/1 mL (NDC 63323-489-27)
Initial Posting
Oct 14, 2016

Reason

Other

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.